Deferred Tax Assets, Net of Valuation Allowance of Talis Biomedical Corp from 31 Dec 2020 to 31 Dec 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Talis Biomedical Corp quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2023.
  • Talis Biomedical Corp Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2023 was $3,666,000, a 51% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Talis Biomedical Corp Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $3,666,000 -$3,803,000 -51% 31 Dec 2023 10-K 28 Mar 2024 2023 FY
Q4 2022 $7,469,000 +$3,404,000 +84% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $4,065,000 +$3,843,000 +1731% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q4 2020 $222,000 31 Dec 2020 10-K 15 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.